Sarah M. Lo, MD, MPH

Clinical Assistant Professor of Pediatrics (Oncology)
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Oncology
3401 Civic Center Blvd
Philadelphia, PA 19104
Division of Oncology
3401 Civic Center Blvd
Philadelphia, PA 19104
Education:
B.A (Political Science)
Barnard College, 1998.
MPH (Public Health)
Columbia University School of Public Health, 2003.
MD
Albert Einstein College of Medicine, 2004.
Permanent linkB.A (Political Science)
Barnard College, 1998.
MPH (Public Health)
Columbia University School of Public Health, 2003.
MD
Albert Einstein College of Medicine, 2004.
Selected Publications
Sohela Shah, Kasmintan A Schrader, Esmé Waanders, Andrew E Timms, Joseph Vijai, Cornelius Miething, Jeremy Wechsler, Jun Yang, James Hayes, Robert J Klein, Jinghui Zhang, Lei Wei, Gang Wu, Michael Rusch, Panduka Nagahawatte, Jing Ma, Shann-Ching Chen, Guangchun Song, Jinjun Cheng, Paul Meyers, Deepa Bhojwani, Suresh Jhanwar, Peter Maslak, Martin Fleisher, Jason Littman, Lily Offit, Rohini Rau-Murthy, Megan Harlan Fleischut, Marina Corines, Rajmohan Murali, Xiaoni Gao, Christopher Manschreck, Thomas Kitzing, Vundavalli V Murty, Susana Raimondi, Roland P Kuiper, Annet Simons, Joshua D Schiffman, Kenan Onel, Sharon E Plon, David Wheeler, Deborah Ritter, David S Ziegler, Kathy Tucker, Rosemary Sutton, Georgia Chenevix-Trench, Jun Li, David G Huntsman, Samantha Hansford, Janine Senz, Thomas Walsh, Ming Lee, Christopher N Hahn, Kathryn Roberts, Mary-Claire King, Sarah M Lo, Ross L Levine, Agnes Viale, Nicholas D Socci, Katherine L Nathanson, Hamish S Scott, Mark Daly, Steven M Lipkin, Scott W Lowe, James R Downing, David Altshuler, John T Sandlund, Marshall S Horwitz, Charles G Mullighan, Kenneth Offit: A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet 45(10): 1226-31, Oct 2013.Lo SM, Choi M, Liu J, Jain D, Boot RG, Kallemeijn WW, Aerts JM, Pashankar F, Kupfer GM, Mane S, Lifton RP, Mistry PK: Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematological malignancy phenotype by individual genome analysis. Blood 119(20): 4731-40, May 2012.
Lo SM, Liu J, Chen F, Pastores GM, Knowles J, Boxer M, Aleck K, Mistry PK: Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy. J Inherit Metab Dis 34(3): 643-50, Jun 2011.
Lo SM, McNamara J, Seashore MR, Mistry PK.: Misdiagnosis of Niemann-Pick Disease type C as Gaucher Disease: lack of response to macrophage-targeted glucocerebrosidase enzyme replacement therapy. J Inherit Metab Dis 33(3): 429–433, Sept 2010.
Lo SM, Stein P, Mullaly S, Bar M, Jain D, Pastores GM, Mistry PK.: Expanding spectrum of the association between type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types – correlation with genotype and phenotype. Am J Hematol 85(5): 340-5, May 2010.
Lo S, Sharif I, Ozuah PO: Health literacy among English-speaking parents in a poor urban setting. J Health Care Poor Underserved 17(3): 504-11, Aug 2006.
Sharif I, Lo S, Ozuah PO.: Availability of Spanish prescription labels. J Health Care Poor Underserved 17(1): 65-9, Feb 2006.
Zelcer S, Kellick M, Wexler LH, Shi W, Sankaran M, Lo S, Healey J, Huvos AG, Meyers PA, Gorlick R: Methotrexate levels and outcome in osteosarcoma. Pediatric Blood Cancer 44(7): 638-42, Jun 2005.